Drug Trials Snapshot: CIBINQO

[FDA]

CIBINQO is a Janus Kinase (JAK) inhibitor that is indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.


Baca selengkapnya di : http://www.fda.gov...